Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates
Go back to Xeris Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Updates| (NASDAQ: XERS) | Delayed: 8.32 +0.33 (4.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.99 | 52 Week High | $ | |||
| Open | $8.00 | 52 Week Low | $ | |||
| Day High | $8.33 | P/E | N/A | |||
| Day Low | $7.96 | EPS | $ | |||
| Volume | 859,536 | |||||
